- Pharmacokinetics of anti-cancer agents
- Development of novel therapy in gastrointestinal and head/neck cancers
Cell Host Microbe. 2019 Feb 14;:
JAMA. 2018 12 18;320(23):2448-2460
Clin Cancer Res. 2018 Oct 15;:
Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer.
Cancer Med. 2018 Oct 14;:
Tumor Platinum Concentrations and Pathological Responses Following Cisplatin-Containing Chemotherapy in Gastric Cancer Patients.
J Gastrointest Cancer. 2018 Aug 16;:
The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy.
Oncotarget. 2018 Apr 17;9(29):20439-20450
A case-control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity.
J Oncol Pharm Pract. 2018 Jan 01;:1078155218771461
Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort.
Head Neck. 2018 Apr 17;:
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial.
Clin Colorectal Cancer. 2018 Mar 08;:
Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer.
JAMA Otolaryngol Head Neck Surg. 2017 Nov 22;:
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Affiliate Scientist, Princess Margaret Cancer Centre
Assistant Professor, Faculty of Medicine, University of Toronto
Staff Oncologist, Princess Margaret Cancer Centre